Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)
This study has been completed.
Sponsor:
UMC Utrecht
Collaborator:
Hoffmann-La Roche
Information provided by:
UMC Utrecht
ClinicalTrials.gov Identifier:
NCT00150904
First received: September 6, 2005
Last updated: February 13, 2009
Last verified: February 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2009 |
| Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |